The GPCR-Gα(s)-PKA signaling axis promotes T cell dysfunction and cancer immunotherapy failure.
Wu VH, Yung BS, Faraji F, Saddawi-Konefka R, Wang Z, Wenzel AT, Song MJ, Pagadala MS, Clubb LM, Chiou J, et al. Nat Immunol. 2023 Aug; 24(8):1318-1330. Epub 2023 Jun 12.